NIDDM-Y in first nation children in Canada

Clinical Pediatrics

Volumn 37, Issue 2, 1998, Pages 89-96

  Dean, Heather ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b CHILDREN S HOSPITAL RESEARCH INSTITUTE OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT; TROGLITAZONE;

ADOLESCENT; CANADA; CHILD; CLINICAL PROTOCOL; CONFERENCE PAPER; DRUG EFFICACY; DRUG SAFETY; GASTROINTESTINAL TOXICITY; GENETIC SUSCEPTIBILITY; HEALTH PROGRAM; HUMAN; JUVENILE DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; RISK ASSESSMENT; SCREENING TEST; TERATOGENICITY; TREATMENT PLANNING; WORLD HEALTH ORGANIZATION;

EID: 0031891229     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/000992289803700205     Document Type: Conference Paper

References (28)

1. Dean HJ, Mundy RL, Moffat M. Noninsulin dependent diabetes mellitus in Indian children in Manitoba. Can Med Assoc J. 1992;147:52-57.
2. Glaser N, Jones KL. Non-insulin dependent diabetes in children and adolescents. Advances in Pediatr. 1996;43:359-381.
3. Dean HJ, Flett B. Population-based fasting blood glucose and insulin levels in Native youth in a remote northern Canadian community. Abstract presented at the First International Conference on NIDDM in Minority Youth, Tucson, Arizona, December 1996.
4. Dean HJ, Flett B. Long-term prognosis for native youth with NIDDM: a case study. Abstract presented at the First International Conference on NIDDM in Minority Youth, Tucson, Arizona, December 1996.
5. Harris SB, Gittelsohn HA, Gittelsohn BA, et al. The prevalence of NIDDM and associated risk factors in Native Canadians. Diab Care. 1997;20:185-187.
6. Young TK. The Health of Native Americans. Towards a Biocultural Epidimiology. Oxford University Press; 1994.
7. Manitoba Health Information Systems, May 1996.
8. Medical Services Branch Manitoba Region, August 1996.
9. Blanchard J, Dean H, Anderson K, Wajda A, et al. The incidence and prevalence of diabetes in Manitoba 1985-1993: children less than 15 years of age. Diab Care. 1997;20:512-315.
10. Hammer LD, Kraemer HC, Wilson DM, et al. Standardized percentile curves of body mass index for children and adolescents. Am J Dis Child, 1991;45:259-263.
11. Anderson K, Dean HJ. The effect of diet and exercise on a native youth with poorly controlled NIDDM. Beta Release. 1990;14:105-106.
12. Dean HJ. Improvement in blood glucose levels at summer camp in children with non-insulin dependent diabetes (NIDDM). Abstract #135 presented at the 3rd International Conference on Diabetes and Indigenous Peoples, Winnipeg, Manitoba, May 1995.
13. Kulesza S, Dean H. Long-term followup of children with non-insulin dependent diabetes (NIDDM) in Manitoba: transition to adult health care. Abstract #122 presented at the 3rd International Conference on Diabetes and Indigenous Peoples, Winnipeg, Manitoba, May 1995.
14. Delisle HF, Ekoe J-M. Prevalence of non-insulin dependent diabetes mellitus and impaired glucose tolerance in two Algonquin communities in Quebec. Can Med Assoc J. 1993;148:41-47.
15. Braun B, Zimmerman MB, Kretchmer N, et al. Risk factors for diabetes and cardiovascular disease in young Australian aborigines. Diabetes Care. 1996;5:472-479.
16. Pettit DJ, Moll PP, Knowler DM, et al. Insulinemia in children at low and high risk of NIDDM. Diab Care. 1993;16:608-615.
17. McCance DR, Pettitt DJ, Hanson RL, et al. Glucose, insulin concrentations and obesity in childhood and adolescence as predictors of NIDDM. Diabetologia, 1994;37:617-623.
18. Young TK, Kaufen JM, McKenzie JK. Excessive burden of end-stage renal disease among Canadian Indians: a national survey, Am J Public Health. 1989;79:756-758.
19. Dyck R, Tan L. Rates and outcomes of diabetic end stage renal disease among registered native people in Saskatchewan, Can Med Assoc J. 1994;150;203-208.
20. Bullock B. Postl BD, Ogborn MR. Excess prevalence of nondiabetic renal disease in native American children in Manitoba. Pediatr Nephrol. 1996;10:702-704.
21. Piacquadio K, Hoolingsworth D, Murphy H. Effects of in-utero exposure to oral hypoglycemic drugs. Lancet. 1991;338:866-869.
22. Hellmuth E, Damm P, Molsted PL. Congenital malformations in off-embryospring of diabetic women treated with oral hypoglycemic agents during embryogenesis. Diabetic Med. 1994;11:471-474.
23. Comess LJ, Bennet PH, Man MB, et al. Congenital anomalies in the Pima Indians of Arizona. Diabetes. 1969;18:471-477.
24. Towner D, Kjos SL, Leung B, et al. Congenital malformations in pregnancies complicated by NIDDM. Diab Care. 1995;18:1446-1451.
25. Kitzmiller JL, Buchanan TA, Kjos S, et al. Preconception care of diabetes, congenital malformations, and spontaneous abortions. Diab Care. 1996;19:514-541.
26. Lewis ES, Hunsickcr LG, Bain RP, Rohde RD for the Collaborative Study Group. The effect of angiotensin-converting enxyme inhibition on diabetic nephropathy. N Engl J Med. 1993;329:1456-1462.
27. Rodby RA, Firth LM, Lewis EJ for the Collaborative Study Group. An economic analysis of captropril in the treatment of diabetic nephropathy. Diab Care. 1996;19:1051-1061.
28. Yokoyama H, Okudaira M, Otani T, et al. Existence of early onset NIDDM in Japanese demonstrating severe diabetic complications. Diab Care. 1997;20:844-847.